Lung disease comprises many disorders that involve the lungs and prevent them from working properly. Different disorders are caused depending on the different parts of the lungs that are affected, like the airways (the tubes that carry oxygen and other gases through the lungs), the lung tissue, or the blood vessels in the lung. Asthma for instance affects the airways, pulmonary fibrosis affects the lung tissue, and pulmonary hypertension affects the blood vessels in the lung.
Have you ever wondered what exactly medical research is and what role it plays in the development of new therapies? These questions are answered while following exciting new discoveries that may prove beneficial for patients with chronic lung disease.
Feinstein Institute researchers are investigating two main aspects of lung disease: inflammation and hypoxia (temporary lack of oxygen) that accompany pulmonary hypertension (the lung disorder in which the blood pressure in the pulmonary artery rises far above normal levels). Their efforts are aimed at identifying new treatments to control the disease and ways to identify patients who have low levels of oxygen in the blood.
Feinstein Institute investigator who studies lung disease is Edmund Miller.